Health & Environmental Research Online (HERO)


Print Feedback Export to File
3857400 
Journal Article 
Absorption, distribution, metabolism, and elimination of 8-2 fluorotelomer alcohol in the rat 
Fasano, WJ; Carpenter, SC; Gannon, SA; Snow, TA; Stadler, JC; Kennedy, GL; Buck, RC; Korzeniowski, SH; Hinderliter, PM; Kemper, RA 
2006 
Toxicological Sciences
ISSN: 1096-6080
EISSN: 1096-0929 
OXFORD UNIV PRESS 
OXFORD 
91 
341-355 
English 
has erratum 3859495 (vol 91, pg 341, 2006)
The absorption, distribution, metabolism, and elimination of [3-14C] 8-2 fluorotelomer alcohol (8-2 FTOH, C7F1514CF2CH2CH2OH) following a single oral dose at 5 and 125 mg/kg in male and female rats have been determined. Following oral dosing, the maximum concentration of 8-2 FTOH in plasma occurred by 1 h postdose and cleared rapidly with a half-life of less than 5 h. The internal dose to 8-2 FTOH, as measured by area under the concentration-time curve to infinity, was similar for male and female rats and was observed to increase in a dose-dependent fashion. The majority of the 14C 8-2 FTOH (> 70%) was excreted in feces, and 37-55% was identified as parent. Less than 4% of the administered dose was excreted in urine, which contained low concentrations of perfluorooctanoate (approximately 1% of total 14C). Metabolites identified in bile were principally composed of glucuronide and glutathione conjugates, and perfluorohexanoate was identified in excreta and plasma, demonstrating the metabolism of the parent FTOH by sequential removal of multiple CF2 groups. At 7 days postdose, 4-7% of the administered radioactivity was present in tissues, and for the majority, 14C concentrations were greater than whole blood with the highest concentration in fat, liver, thyroid, and adrenals. Distribution and excretion of a single 125-mg/kg [3-14C] 8-2 FTOH dermal dose following a 6-h exposure in rats was also determined. The majority of the dermal dose either volatilized from the skin (37%) or was removed by washing (29%). Following a 6-h dermal exposure and a 7-day collection period, excretion of total radioactivity via urine (< 0.1%) and feces (< 0.2%) was minor, and radioactivity concentrations in most tissues were below the limit of detection. Systemic availability of 8-2 FTOH following dermal exposure was negligible. 
8-2 fluorotelomer alcohol; absorption; distribution; metabolism; and elimination (ADME); glutathione conjugates; perfluorinated carboxylic acids; perfluorooctanoate; peroxisome proliferation; pharmacokinetics 
• Additional PFAS (formerly XAgency)
• Expanded PFAS SEM (formerly PFAS 430)
     Litsearch: September 2019
          PubMed
     Not prioritized for screening
     3:2 Fluorotelomer alcohol
• FtOH 8:2
     Literature Search
          Pubmed
          WOS
     Screening Results
          Toxicokinetic studies
               ADME
• ^Per- and Polyfluoroalkyl Substances (PFAS)
     PFHxA (307-24-4)
          Literature Search
               Pubmed
               WOS
     FtOH 8:2 (678-39-7)
          Literature Search
               Pubmed
               WOS
• PFAS 150
     Literature Search Update December 2020
          PubMed
     Literature Search August 2019
          PubMed
          Web of Science
          Other sources
               Reference list review of included studies
     Screened Studies
          Supplemental
     7:3 Fluorotelomer alcohol
     8:2 Fluorotelomer alcohol
     Perfluorooctanoic acid
• PFBA
     Protocol References
• PFHxA
     Literature Search
          Pubmed
          WOS
     LitSearch Update: February 2018
          Term Set 2: Initial Search
               PubMed
               WoS
     Literature Search
          Pubmed
          WOS
     Scopus: April 2021
     Screening Results
          Excluded/Not on Topic
     Title and Abstract Screening
          Excluded
               Not relevant to PECO
     HAWC
• Yale PFAS Liver study